Abstract:OBJECTIVE:Cellular response to estradiol is mediated both by estrogen receptor (ER) binding to estrogen response element (ERE) and by non-nuclear actions like activation of signal transduction pathways such as mitogen activated protein kinase (MAPK) pathway. However, the signal transduction of estrogen involving phosphatidylinositol 3-kinase-protein kinase B (PI3K-PKB) is not clear in endometrial carcinoma. Our purpose was to study if PI3K-PKB signaling pathway could be activated rapidly by 17beta-E(2) through non-nuclear action and also, whether PI3K inhibitor, LY294002, could inhibit such non-nuclear action of 17beta-E(2) in endometrial carcinoma cell line Ishikawa. METHODS:Levels of phosphorylated PKB (Ser473 site, p-PKB) and total PKB were examined by western blotting in Ishikawa cells after stimulation with 17beta-E(2) at 1 x 10(-6) mol/L for different time periods and at varied doses for 30 min. Optimal time and appropriate dose for 17beta-E(2) to activate PKB in Ishikawa cells were observed. Inhibitory effect of LY294002 on activation of PKB induced by 17beta-E(2) was also studied. p-PKB/PKB ratio was used to indicate levels of activation of PKB. RESULTS:p-PKB/PKB at 15 min (0.533 +/- 0.029) was significantly higher than the control (0.361 +/- 0.029, P < 0.05). Maximal activation of PKB (maximal levels of p-PKB/PKB) took place at 30 min (0.666 +/- 0.021, P < 0.001) and the activation persisted at least 2 h after stimulation with 1 x 10(-6) mol/L 17beta-E(2) in Ishikawa cells. With increased doses of 17beta-E(2) (vehicle, 1 x 10(-10), 1 x 10(-8), 1 x 10(-6), 1 x 10(-4) mol/L), the activation of PKB (p-PKB/PKB was 0.300 +/- 0.098, 0.312 +/- 0.081, 0.625 +/- 0.100, 0.771 +/- 0.041, 0.902 +/- 0.043 accordingly) increased gradually (in comparison with vehicle, P > 0.05, < 0.05, < 0.05, < 0.001 accordingly). PI3K inhibitor, LY294002 could inhibit the activation of PKB induced by 17beta-E(2) in Ishikawa cells. Levels of PKB (p-PKB/PKB) decreased (0.443 +/- 0.032, 0.415 +/- 0.032, 0.111 +/- 0.035, 0, 0) gradually with increased concentrations (vehicle, 0.1, 10, 50, 100 micro mol/L) of LY294002 (compared with vehicle, P > 0.05, < 0.05, < 0.001, < 0.001) and 50 micro mol/L LY294002 completely blocked the activation of PKB induced by 17beta-E(2). CONCLUSIONS:17beta-estradiol, by non-nuclear action, can activate promptly PI3K-PKB signaling pathway in endometrial carcinoma cell line, Ishikawa. This action of 17beta-E(2) is PI3K dependent and can be inhibited or blocked by LY294002.

Regulation of Integrin β3 Expression in Endometrial Carcinoma Cells by Estrogen, Progestin and Heparin-Binding Epidermal Growth Factor

Effect of GSK-3β on Proliferation and Invasion of Endometrioid Adenocarcinoma

[Regulation of Human Progesterone Receptor Isoforms A and B in Uterine Endometrial Carcinoma by Estrogen and Insulin-Like Growth Factor-1].

Regulation of IGFs Expression in Endometrial Carcinoma Cells by Estrogen and Progesterone

Multifactor Regulation on Expressions of MMP-9 and TIMP-1 in Endometrial Stromal Cells

Expression and Regulation of Osteopontin in Ishikawa Cell Line

[Expression of Integrin Beta 3 and Intracellular Adhesion Molecule in Endometrium and Endometriotic Tissue].

Regulated Expression of Heparin‐binding EGF‐like Growth Factor (HB‐EGF) in the Human Endometrium: A Potential Paracrine Role During Implantation

Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients

[Regulation of Orphan Receptor ERR Alpha by Estrogen and Progesterone in Endometrial Carcinoma Cell Line].

Study on the expression of IL-6/STAT3 in endometrial cancer cells mediated by GPR30

Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing

Effects of Estrogen, Progestin and Mifepristone on Endometrial Carcinoma Cell Lines

Regulation of Human Progesterone Receptor Isoforms A and B in Uterine Endometrial Cardmoma by Estrogen

Nuclear Estrogen Receptor-Mediated Notch Signaling and GPR30-mediated PI3K/AKT Signaling in the Regulation of Endometrial Cancer Cell Proliferation.

[Regulatory Effect of 17Beta-Estradiol on Expression of Orphan Nuclear Receptor ERRalpha in Endometrial Carcinoma Cell Lines].

[Activation of Phosphatidylinositol 3-Kinase-protein Kinase B (PI3K-PKB) Induced by 17Beta-Estradiol in Endometrial Carcinoma Cell (Ishikawa)].

Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.

Over-expression EGFR reduced sensitivity of human endometrial carcinoma cells to progesterone

The Expression of SIRT3 in Endometrial Carcinoma and Its Effect on Promoting Apoptosis of Ishikawa Cells

17Β-Estradiol Activates PI3K/Akt Signaling Pathway by Estrogen Receptor (Er)-Dependent and ER-independent Mechanisms in Endometrial Cancer Cells